surmount-1 tirzepatide trial weight loss non-diabetic vs semaglutide: A new battle in obesity treatment Diabetes Distilled: “Twincretin” tirzepatide significantly

Data and documents, including the study protocol, statistical analysis plan, clinical study report, and blank or annotated case report forms, will be provided in a secure data sharing environment

And, Changing patterns of contraceptive use show routine contraception utilization down by 3% in 2023, and at the same time, emergency contraception use and sterilization visits up 35% and 11%, respectively

A board-certified surgeon breaks down which procedures work best and what the research shows.

In July 2000, FDA approved Sarafem (fluoxetine) for use in Pre-Menstrual Dysphoric Disorder (PMDD)

Cardiometabolic Markers Secondary endpoints in published trials have included blood pressure, lipid panel, and inflammatory markers, giving researchers additional data points for modeling broader cardiometabolic effects of triple agonism